Related Experiment Videos
Immune function assays as indicators of chromate exposure
1Institute of Environmental Medicine, New York University Medical Center, NY 10016.
Environmental Health Perspectives
|May 1, 1991
Summary
Chromium exposure can alter immune responses. Studies show chromium inhibits T- and B-lymphocyte activity in vitro but may enhance responses in vivo, suggesting potential immune sensitization and use as a biomarker.
Area of Science:
- Immunology
- Environmental Toxicology
- Cell Biology
Background:
- Chromium compounds are environmental contaminants with potential health effects.
- Understanding chromium's impact on the immune system is crucial for risk assessment.
Purpose of the Study:
- To investigate the immunomodulatory effects of chromium (K2CrO4) in vitro and in vivo.
- To determine if chromium exposure can induce immune sensitization.
- To explore the potential of chromium-induced immune responses as a biological marker.
Main Methods:
- In vitro studies using T-lymphocyte and B-lymphocyte mitogen cultures exposed to varying chromium concentrations.
- In vitro mixed lymphocyte cultures to assess antigen-induced thymidine uptake.
- In vivo studies involving rats exposed to chromium in drinking water, followed by splenocyte analysis.
Main Results:
- In vitro, chromium inhibited T-lymphocyte responses and, at higher concentrations, B-lymphocyte responses.
- In mixed lymphocyte cultures, chromium inhibited responses at high concentrations but enhanced them at 0.1 mg/L.
- Splenocytes from chromium-exposed rats showed enhanced responses to mitogens, with further enhancement upon in vitro chromium addition.
Conclusions:
- Chromium exhibits complex immunomodulatory effects, inhibiting lymphocyte proliferation in vitro but potentially inducing sensitization in vivo.
- Enhanced splenocyte responses in chromium-exposed rats suggest chromium-induced immune sensitization.
- These findings indicate that chromium-induced immune changes may serve as a potential biological marker for chromium exposure.